Ledger.Open graph →
SEC Form D · filed January 4, 2019

Ribon Therapeutics, Inc

Offering
$65.0M
Sold
$25.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LEXINGTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Cameron M. Wheeler · Lexington, MADirectorJonathan M. Root · Lexington, MADirectorDavid M. Cordo · Lexington, MAExecVictoria M. Richon · Lexington, MAExec · DirectorMarian M. Nakada · Lexington, MADirectorSteve A. Tran · BOULDER, COExec · DirectorEugene S. Rosenfelt · San Francisco, CAExecLarry A. Schwartz · BOULDER, CODirectorCharles N. Corfield · BOULDER, CODirectorAnja M. Koenig · Lexington, MADirectorJames M. Audia · Lexington, MADirectorSvennilson Peter · Lexington, MADirectorJohn Garofalo · Concord, MADirectorStefan Kowski · London, United KingdomDirectorStephen Peel · London, United KingdomExec · DirectorDong Shin Kim · SAN MATEO, CAExecAnja M. Koenig · Lexington, MADirectorJames M. Audia · Lexington, MADirectorMarian M. Nakada · Lexington, MADirectorSvennilson Peter · Lexington, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗